Liu, X.M., Liu, X.D., Zhang, Y.Q., Liu, Y.T., Lv, L.W., Wang, M.H., Ren, Q., Liu, Y., Wu, M.Z., Shi, Y.X., Zhang, Y.X., Li, B. (2025). Deciphering the anti-senescent effects of Clioquinol: Lifespan prolongation, metabolic homeostasis, and phenotypic rehabilitation in Drosophila melanogaster.  Free Radical Biol. Med. 238(): 246--260.

FBrf0263289

Research paper

Clioquinol (CQ), a halogenated 8-hydroxyquinoline, was once an oral antiparasitic for intestinal amoebiasis in the 1950s-1970s but was withdrawn due to neurotoxicity. Lately, it shows activities beyond antimicrobials, like in osteoarthritis and neurodegenerative diseases, yet its anti-aging effects are unclear. This study used Drosophila melanogaster to test CQ's effects on healthy aging and age-related diseases. Results showed CQ extended lifespan in normal or high-fat diet flies, enhanced stress resistance and glycolipid metabolism, improved motility, and prevented intestinal inflammation and obesity, and alleviated age-related digestive decline. In addition, CQ also prolonged lifespan and improved motor activity in Alzheimer's flies. Gene-deficient lifespan experiments and transcriptomic analysis revealed CQ's anti-aging mechanisms involving multiple signaling pathways, such as differential gene expression in HIF-1 signaling, Notch signaling, P53 signaling, JAK-STAT signaling, FOXO signaling, and IL-17 signaling pathway, activated TNF signaling and PI3K-Akt signaling pathway, and inhibited mTOR signaling pathway. Overall, CQ shows promise as a candidate for anti-aging interventions and treating aging-related diseases.